Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
PMV Pharmaceuticals, Inc. (PMVP) had Free Cash Flow per Share of $-0.37 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-18.04M |
|
-- |
|
-- |
|
$19.02M |
|
$-19.02M |
|
$0.98M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-18.04M |
|
$-19.02M |
|
$-19.37M |
|
53.33M |
|
53.33M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$95.78M |
|
$0.20M |
|
$0.78M |
|
$96.56M |
|
$8.60M |
|
-- |
|
-- |
|
$8.60M |
|
$87.97M |
|
$87.97M |
|
$87.97M |
|
53.33M |
|
| Cash Flow Statement Financials | |
$-19.68M |
|
$20.82M |
|
-- |
|
$37.98M |
|
$39.13M |
|
$1.15M |
|
$1.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.51% |
|
-20.51% |
|
-18.68% |
|
-20.51% |
|
$1.65 |
|
|
Free Cash Flow per Share |
$-0.37 |
$-0.37 |
|